Human Milk Oligosaccharides Market Size, Share & Trends Analysis Report By Type (2'FL, 6'SL), By Concentration, By Application (Infant Formula, Dietary Supplement), By Region, And Segment Forecasts, 2023 - 2030

Human Milk Oligosaccharides Market Growth & Trends

The global human milk oligosaccharides market size is expected to reach USD 47,587.77 million by 2030, expanding at a CAGR of 17.6% from 2023 to 2030, according to a new report by Grand View Research, Inc. The global market for human milk oligosaccharides (HMOs) is being driven by several key factors. Firstly, there is a growing awareness among consumers about the health benefits of HMOs. Human milk is known to contain a complex mixture of bioactive compounds, and HMOs are one of the most abundant components. HMOs play a crucial role in supporting the development of a healthy immune system, promoting the growth of beneficial gut bacteria, and reducing the risk of certain diseases.

Secondly, there is an increasing demand for HMOs in the infant formula industry. As breastfeeding rates decline and more infants are fed with formula, manufacturers are seeking to bridge the nutritional gap between breast milk and formula. HMOs are being recognized as valuable additions to infant formula, as they can help mimic the benefits of human milk and provide a more complete nutritional profile for infants.

Furthermore, the market for HMOs is also being driven by advancements in biotechnology and production techniques. Traditionally, HMOs were extracted from human breast milk, which limited their availability and made them expensive. However, researchers have developed innovative methods to produce HMOs through microbial fermentation, making them more accessible and cost-effective. This has opened up new opportunities for HMO production and expanded their potential applications.

In May 2022, Nestlé China launched three new infant formulas containing human milk oligosaccharides (HMOs) for newborns with allergies to cow milk protein. The products are available via cross-border e-commerce as China does not allow HMOs in infant formula.

Human Milk Oligosaccharides Market Report Highlights

• 2’FL dominated the product type segment with a revenue share of over 35.69% in 2022 owing to the growing demand for infant formula that contains HMOs, particularly in regions where breastfeeding rates are low
• The neutral concentration dominated the market with a market share of 51.7% in 2022. These HMOs are the most abundant type found in breast milk, and they serve as a source of energy for the infant and play a role in promoting the growth of beneficial gut bacteria
• The infant formula was the dominant application in the global market, making up 71.94% of the total revenue in 2022. HMOs in infant formulas are in high demand for their benefits: gut health, memory enhancement, brain development, infection prevention, and prebiotic effects
• Some of the key players in the market include Inbiose NV; Elicityl S.A.; Jennewein Biotechnologie GmbH; Medolac Laboratories; Glycom A/S; ZuChem Inc.; Glycosyn LLC; Abbott; Dextra Laboratories Ltd; DuPont.

Please note The report will be delivered in 4-8 business days upon order notification.